These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22333475)

  • 1. [Mechanisms and strategies of glucocorticoid insensitivity in the treatment of chronic obstructive pulmonary disease].
    Xin XF
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):852-4. PubMed ID: 22333475
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucocorticoid pathways in chronic obstructive pulmonary disease therapy.
    Adcock IM; Ito K
    Proc Am Thorac Soc; 2005; 2(4):313-9; discussion 340-1. PubMed ID: 16267355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment.
    Mroz RM; Holownia A; Chyczewska E; Braszko JJ
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():35-42. PubMed ID: 19218631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in mechanisms influencing glucocorticoid sensitivity: the need for a systems biology approach to treatment of glucocorticoid-resistant inflammation.
    Keenan CR; Radojicic D; Li M; Radwan A; Stewart AG
    Pharmacol Ther; 2015 Jun; 150():81-93. PubMed ID: 25596317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of glucocorticoid action and insensitivity in airways disease.
    Boardman C; Chachi L; Gavrila A; Keenan CR; Perry MM; Xia YC; Meurs H; Sharma P
    Pulm Pharmacol Ther; 2014 Dec; 29(2):129-43. PubMed ID: 25218650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid insensitivity as a source of drug targets for respiratory disease.
    Ammit AJ
    Curr Opin Pharmacol; 2013 Jun; 13(3):370-6. PubMed ID: 23434363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhaled glucocorticosteroids in the treatment of asthma and chronic obstructive pulmonary disease].
    Obojski A; Dobek R; Panaszek B
    Pneumonol Alergol Pol; 2004; 72(5-6):226-32. PubMed ID: 15757265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological therapy of chronic obstructive pulmonary disease].
    Montuschi P
    Ann Ist Super Sanita; 2003; 39(4):557-72. PubMed ID: 15098576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.
    Newton R; Leigh R; Giembycz MA
    Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of inhalatory glucocorticosteroids in the treatment of chronic obstructive pulmonary disease].
    Ovcharenko SI; Golikova EP
    Ter Arkh; 2005; 77(11):81-7. PubMed ID: 16404869
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of glucocorticoid on IL-8 expressing in lung tissue of rat with chronic obstructive pulmonary disease].
    Zhang Y; Yang SR; Cheng DY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):287-90. PubMed ID: 17441351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of corticosteroids in acute exacerbations of chronic obstructive pulmonary disease.
    Novak B
    Crit Care Nurse; 2002 Oct; 22(5):80-1. PubMed ID: 12382621
    [No Abstract]   [Full Text] [Related]  

  • 13. Prednisone for chronic obstructive pulmonary disease.
    Hurst JR; Donaldson GC; Wedzicha JA
    N Engl J Med; 2003 Sep; 349(13):1288-90; author reply 1288-90. PubMed ID: 14510014
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.
    Irwin RS; Madison JM
    N Engl J Med; 2003 Jun; 348(26):2679-81. PubMed ID: 12826643
    [No Abstract]   [Full Text] [Related]  

  • 15. Prednisone for chronic obstructive pulmonary disease.
    Salloum A; Elbaage TY; Soubani AO
    N Engl J Med; 2003 Sep; 349(13):1288-90; author reply 1288-90. PubMed ID: 14510016
    [No Abstract]   [Full Text] [Related]  

  • 16. Prednisone for chronic obstructive pulmonary disease.
    Busti AJ; Vervan MD; Brouse SD
    N Engl J Med; 2003 Sep; 349(13):1288-90; author reply 1288-90. PubMed ID: 14507955
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molecular mechanisms of glucocorticoids].
    Cosío BG; Torrego A; Adcock IM
    Arch Bronconeumol; 2005 Jan; 41(1):34-41. PubMed ID: 15676134
    [No Abstract]   [Full Text] [Related]  

  • 18. Prednisone for chronic obstructive pulmonary disease.
    Rolla G; Bucca C
    N Engl J Med; 2003 Sep; 349(13):1288-90; author reply 1288-90. PubMed ID: 14510015
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic-obstructive pulmonary disease. Medical treatment].
    Randerath W; Galetke W; Karl-Heinz R
    Med Monatsschr Pharm; 2002 May; 25(5):150-8; quiz 158, 168. PubMed ID: 12050920
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic obstructive pulmonary disease.
    Kerstjens H; Postma D
    Clin Evid; 2003 Jun; (9):1645-63. PubMed ID: 12967439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.